Monkeypox cases are investigated in the U.S., Canada and Europe. Usually, the ilness is most common in remote parts of Central and West Africa. It’s a rare viral infection which is usually mild and from which most people recover in a few weeks. The virus can enter the body through broken skin, the respiratory tract or through the eyes, nose or mouth. Symptoms include a rash, fever, headache, muscle aches, backache, swollen lymph nodes, chills and exhaustion. The lesions can cause scarring. Monkeypox can sometimes be more severe but has only been fatal in rare cases. The infections can be deadly for up to one in 10 people who has the virus. The virus does not spread easily between people so the risk to the wider public is said to be very low. Two of the infected patients in the UK traveled from Nigeria.
The four most recent cases , three in London and one in north-east England , do not have any known links with each other, or any history of travel. In 2017, Nigeria experienced the largest documented outbreak. There were 172 suspected cases and 75% of victims were males aged between 21 and 40 years old. There is no treatment for monkeypox but a vaccine was approved. “We really need to better understand the extent of monkeypox in endemic countries… to really understand how much is circulating and the risk that it poses for people who are living there, as well as the risk of exportation,” infectious disease epidemiologist Dr. Maria Van Kerkhove said at a WHO press conference on Tuesday.